Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma

Figure 3

Survival analyses of GBM patients in our medical center. Cancer-specific survival analyses were conducted according to patients’ age (a), sex (b), glioblastoma site (c), tumor size (d), surgical resection pattern (e), and NKD1 protein level (f), respectively.

(a)

(b)

(c)

(d)

(e)

(f)